基于液相色谱-质谱联用技术的代谢组学方法用于中药通心络和人参对过度疲劳大鼠干预作用的评价

用代谢组学方法评价了中药通心络和人参对过度疲劳大鼠的干预作用.通过构造大鼠过度疲劳模型,并分别用通心络和人参进行干预,采用快速液相色谱-离子阱飞行时间质谱(UFLC-IT-TOF-MS)获取大鼠血浆代谢轮廓,并用正交偏最小二乘法(OPLS)进行多变量统计分析,分别找出用于区分通心络和人参干预组大鼠同正常对照大鼠、过度疲...     

液相色谱-线性离子阱-静电场轨道阱回旋共振组合质谱法鉴定乙胺嘧啶在大鼠体内的代谢物

研究乙胺嘧啶在大鼠体内的代谢方式与途径.大鼠以5 mg/kg单剂量口服乙胺嘧啶后,在不同时间点分别采集其血液、尿液和粪便样品.采用液相色谱-线性离子阱-静电场轨道阱回旋共振组合质谱仪(LC-LTQ-Orbitrap)检测乙胺嘧啶在大鼠体内的代谢物,结合相关代谢软件,共鉴定出10种代谢产物,主要的代谢途径包括苯环上的羟基化、N-氧化、双氧化、Ⅳ-葡萄糖醛酸结合、甲基化+葡萄糖醛酸结合、羟基化+葡萄糖醛酸结合和Ⅳ-氧化+葡萄糖醛酸结合.除乙胺嘧啶3-N-氧化物已经在大鼠体外代谢研究中被发现外,其余9种代谢产物均首次在大鼠体内发现.根据其精确分子量及多级质谱的碎片特征,对这些代谢产物的化学结构做出推断,并建立乙胺嘧啶在大鼠体内的代谢谱系.研究表明,乙胺嘧啶在大鼠体内的Ⅰ相代谢方式主要是羟基化和N位氧化,Ⅱ相代谢方式主要是甲基化和葡萄糖醛酸结合.     

柴胡皂苷A对抑郁模型大鼠脑中单胺类神经递质及其代谢产物含量的影响

在酸性条件下, 利用高效液相色谱法研究了柴胡皂苷A对抑郁模型大鼠脑中单胺类神经递质及其代谢物含量的影响. 实验结果表明, 柴胡皂苷A可使抑郁型大鼠脑中的高香草酸、去甲肾上腺素、多巴胺及5-羟色胺的含量升高, 这一结果有利于对柴胡皂苷治疗抑郁症的物质基础及相关机理进行更深入了解.     

黄芪黄酮干预脾虚水湿不化大鼠血浆代谢组学研究

采用高效液相色谱结合飞行时间质谱检测正常大鼠、脾虚水湿不化证大鼠及黄芪黄酮组分干预后大鼠血浆内源性代谢物变化,获取大鼠血浆代谢图谱,研究黄芪黄酮组分干预脾虚水湿不化证的作用机制.采用高脂低蛋白饮食加负重游泳力竭建立脾虚水湿不化证大鼠模型,选择Halo C18色谱柱,流动相为0.05％甲酸-水与0.05％甲酸-乙腈,梯度洗脱,利用液相色谱-串联质谱分析测定大鼠血浆样品.利用主成分分析法对造模前后大鼠血浆样本进行代谢轮廓分析,结合变量投影重要性及显著性分析等筛选对分组贡献最大的差异标志物及相关通路,阐明药物的作用机制.结果表明, 黄芪黄酮组代谢轮廓异于模型组,而接近于正常组,共鉴定出了包含甘油磷脂类、鞘酯类、氨基酸类等在内的11种潜在生物标志物,其代谢通路包括三羧酸循环、甘油磷脂代谢、脂肪酸代谢及氨基酸代谢等,主要涉及体内能量代谢和脂肪代谢.黄芪黄酮干预脾虚水湿不化证大鼠后, 宏观指标(如体重、自主活动)和微观指标(如代谢标志物、血脂)均明显回调,表明黄芪黄酮可能主要通过调节能量代谢、脂肪代谢等途径而发挥健脾利水作用.     

大鼠尿液中壬基酚的代谢轮廓

运用代谢组学方法研究了壬基酚对大鼠尿液代谢的影响, 通过高效液相色谱-飞行时间质谱技术建立了大鼠尿样的代谢指纹图谱, 用主成分分析法分析给药组与对照组代谢物指纹图谱的差异, 通过t检验选取潜在的生物标志物及效应标志物, 并结合代谢物数据库检索对其进行鉴定. 结果表明, 壬基酚给药后, 尿液中含量变化显著的成分苯基葡萄糖苷酸、L-高半胱氨酸、3-硝基丙酸、肌酸酐、左旋肉碱及5-羟色胺等构成了大鼠尿液代谢的轮廓, 它们在生物体内的变化可能对生殖系统、免疫系统、神经系统及脂肪的代谢造成一定的影响, 从代谢的角度解释了环境雌激素壬基酚对生物体的危害, 为毒理学研究提供了依据.     

高效液相色谱-串联质谱及特异性抑制剂探针方法研究异嗪皮啶的体外CYP450代谢产物及代谢亚型

利用高效液相色谱-串联质谱及特异性抑制剂探针方法研究了异嗪皮啶在大鼠肝微粒体CYP450中的代谢产物及代谢亚型。结果表明,异嗪皮啶在大鼠肝微粒体的代谢时间为2 h最佳,其主要代谢产物有5种。CYP 3A,CYP 2C,CYP 2E1等亚型为异嗪皮啶在大鼠肝微粒体内的主要代谢酶。本方法为进一步研究药物-药物相互作用提供了依据。     

N-乙酰半胱氨酸保护下给药钆-二乙三胺五乙酸后慢性肾衰大鼠的尿液代谢组学研究

N-乙酰半胱氨酸(NAC)有减轻造影剂引发肾损伤的作用,但其作用机制尚未明确.本研究采用基于1H NMR的代谢组学方法,结合正交偏最小二乘法判别分析(OPLS-DA),在NAC保护下对慢性肾衰大鼠给药造影剂钆-二乙三胺五乙酸(Gd-DTPA), 通过分析大鼠尿液中内源性代谢物的变化,研究了NAC对慢性肾衰大鼠的保护机制.结果表明,慢性肾衰大鼠能量代谢、尿素循环等代谢通路发生紊乱.给药Gd-DTPA后,大鼠尿液中胆碱、N-氧三甲胺、邻羟基苯乙酸苯酯、对羟基苯乙酸苯酯、马尿酸、甘氨酸、烟酸、牛磺酸减少,尿囊素增加;而在NAC保护下相关代谢产物向模型组的恢复,说明NAC对Gd-DTPA引发的大鼠肠道细菌代谢、肝线粒体代谢、犬尿氨酸代谢紊乱及氧化损伤具有一定修复作用.NAC对尿素循环代谢的改善可能减轻大鼠体内的肾损伤,而其对细胞中谷胱甘肽的补充可能减轻Gd-DTPA造成的氧化损伤.     

利用氢化物发生-冷阱捕集-原子吸收光谱联用技术测定雄黄染毒大鼠血中砷的含量

采用氢化物发生-冷阱捕集-原子吸收光谱法(HG-CT-AAS)测定了雄黄染毒大鼠血中不同形态砷的含量.结果表明,雄黄在大鼠体内的代谢产物为无机砷、一甲基胂酸和二甲基胂酸,其中二甲基胂酸是主要代谢产物;3种形态砷的精密度、准确度、回收率及线性关系良好.     

非靶向代谢组学用于藜芦妨害人参治疗脾气虚的机制研究

采用超高效液相色谱串联四级杆飞行时间质谱( UPLC/Q-TOF-MS)联用技术,通过非靶向代谢组学方法分析大鼠尿液内源性代谢物的变化,研究藜芦妨害人参发挥药效作用的机制。建立脾气虚大鼠模型,连续给药15天,测定力竭游泳时间及血液中白细胞、红细胞、血红蛋白的含量。结果表明,人参可显著提高脾气虚模型大鼠的力竭游泳时间(p﹤0.01),升高白细胞、红细胞及血红蛋白含量(p﹤0.05,p﹤0.01),藜芦对脾气虚模型大鼠各项指标无明显影响(p>0.05),人参与藜芦配伍后对脾气虚模型大鼠各项指标均无显著影响(p>0.05),表明藜芦妨害了人参发挥药效作用。采用UPLC/Q-TOF-MS技术及非靶向代谢组学的方法分析了空白组、模型组、人参组、藜芦组、参藜组对脾气虚模型大鼠的尿液代谢组差异,其中主成分分析( PCA)得分图显示各组代谢轮廓有显著差别,并通过正交偏最小二乘法-判别分析( OPLS-DA)及数据库检索,鉴定出15种人参干预调节脾气虚模型大鼠的潜在生物标志物,从中找出了7种人参藜芦配伍后减弱人参上述干预作用的潜在生物标志物,并对其涉及的代谢通路进行了系统分析。上述研究结果表明,人参藜芦配伍后妨害了人参对脾气虚模型大鼠的治疗作用,其机理可能是影响人参对体内能量代谢、免疫平衡及氧化还原反应等相关代谢的调节。     

黄芪口服液降低大鼠顺铂毒性作用机制的尿液代谢组学研究

采用基于液相色谱-飞行时间质谱联用(LC-TOF-MS)技术的代谢组学方法,分析大鼠尿液内源性代谢物的变化,研究黄芪口服液(HO)降低大鼠顺铂(CDDP)毒性的作用机制.采用低剂量多次腹腔注射CDDP的方法建立CDDP染毒大鼠模型,并连续给予16天HO.于第18天收集正常对照(Control)组、顺铂模型(CDDP)组和黄芪口服液(HO)组大鼠的24 h尿液, 进行LC-TOF-MS分析,以获取尿液代谢物组数据集,对所得数据进行主成分分析(PCA)和正交偏最小二乘法-判别分析(OPLS-DA)等多元统计分析,以筛选潜在生物标志物.于第20天采集大鼠血清测定肌酐和尿素氮水平.血清指标测定结果表明, HO可以显著降低CDDP染毒大鼠的肌酐和尿素氮水平(p<0.05).PCA得分图显示,3组可分别聚类,HO组位于Control组和CDDP组中间,表明HO可部分改善CDDP所致大鼠尿液代谢产物的异常变化.综合OPLS-DA分析、t检验和倍数变化分析结果,最终共筛选并初步鉴定出35个尿液代谢产物作为HO减毒相关的潜在生物标记物.代谢通路分析结果表明,HO可通过纠正体内氨基酸代谢、能量代谢和核苷酸代谢等通路的紊乱,降低CDDP所致机体毒性.     

Metabonomics study on the effect of Siwu Decoction for blood deficiency syndrome in rats using UPLC–Q/TOF–MS analysis

Siwu decoction (SWD), a traditional Chinese medicinal formula with over 1000 years of clinical history, is widely used for gynecological disease, especially blood deficiency syndrome, which is similar to anemia in modern medicine. In view of metabonomics being useful approach to investigate the potential mechanisms of action from the point of view of systems biology, in this study an ultra‐performance liquid chromatography–quadrupole‐time of flight mass spectrometry method was employed for a holistic evaluation of SWD on a blood‐deficiency rat model induced by N‐acetylphenylhydrazine and cyclophosphamide via plasma metabonomics study. Routine blood examination results showed that SWD could significantly improve the declining hemogram indices. Meanwhile, the plasma metabonomics profiles in different groups were analyzed and differentiating metabolites were primarily visualized through chemometric analysis. Seven biomarkers were identified in plasma samples of blood‐deficiency rat model compared with the normal group. Five main metabolism pathways were suggested using the Kyoto Encyclopedia of Genes and Genomes Pathway Analysis and Pathway Activity Profiling algorithm analysis. This indicated that SWD played a therapeu role in blood deficiency by regulating the aberrant endogenous metabolites. To sum up, this study provides clear evidence that a metabonomics study could serve as a useful tool to elucidate the systematic therapeutic profiles and mechanisms for blood deficiency syndrome of Chinese herbal medicines.     

Metabonomics Study of TCM Formula: Qutan Huayu Tongmai Granule as an Effective Treatment for Atherosclerosis in Mini-Pigs

To investigate the effects of QuTan HuaYu TongMai granule (QHTG) on the perturbed metabolism of atherosclerosis mini-pig model, a serum metabonomics method based on Liquid chromatography/mass spectrometry was developed. Principal component analysis and partial least squares-discriminate analysis models were established for the metabonomics analysis. The effect of high dose QHTG group is equivalent with those of positive drugs group in PCA score plots. Some significantly changed metabolites, including lyso-PCs, metabolites of vitamin D₃ and fatty acids were found to be reasonable in explaining the anti-atherosclerosis mechanism of QHTG. Metabonomic approach is helpful to further understand the pathophysiology of atherosclerosis in mini-pigs and the therapeutic mechanism of QHTG. Our work also indicated that the LC–MS based metabonomics method is a potential tool for performing intervention and mechanism research of traditional Chinese medicine (TCM).

     

Metabonomic study on 'Kidney-Yang Deficiency syndrome' and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry

This paper was designed to study metabonomic characters of the ‘Kidney-Yang Deficiency syndrome’ induced by high dose of hydrocortisone and the therapeutic effects of Rhizoma Drynariae, classic traditional Chinese medicine (TCM) in treating the syndrome. A urinary metabonomics method based on ultra-performance liquid chromatography coupled with mass spectrometry (UPLC/MS) was developed. The significant difference in metabolic profiling was observed from model group (hydrocortisone-induced group) compared with the pre-dose group (rats before hydrocortisone inducing) by using the principal components analysis (PCA). The time-dependent regression tendency in Rhizoma Drynariae treatment group (hydrocortisone-induced rats followed by being administered with Rhizoma Drynariae ethanol extracts) from day 3 to 15 was obtained, indicating the time-dependent recovery effect of Rhizoma Drynariae on ‘Kidney-Yang Deficiency syndrome’ rats. Some significantly changed metabolites like phenylalanine, phenylacetylglycine, N₂-succinyl-l-ornithine, l-proline, creatinine, hippurate and citrate have been identified. These biochemical changes are related to the disturbance in energy metabolism, amino acid metabolism and gut microflora, which are helpful to further understand the ‘Kidney-Yang Deficiency syndrome’ and the therapeutic mechanism of Rhizoma Drynariae. The work shows that the metabonomics method is a valuable tool for studying the essence of Chinese medicine's syndrome theory and therapeutic effect mechanism of TCM.     

Urinary metabonomic study using a CUMS rat model of depression

Chronic unpredictable mild stress (CUMS) is a well‐validated model of depression. In this study, a urinary metabonomics method based on the NMR spectrometry was used to study the metabolic perturbation in CUMS‐induced rat depression model. With pattern recognition analysis, a clear separation of CUMS rats and healthy controls was achieved, and nine endogenous metabolites contributing to the separation were identified. CUMS‐treated rats were characterized by the increase of glycine, pyruvate, glutamine, and asparagines, as well as the decrease of 2‐oxoglutarate, dimethylglycine, citrate, succinate, and acetate. The urinary biochemical changes related to the metabolic disturbance in CUMS induced depression, and the possible correlations with live qi stagnation in traditional Chinese medicine are discussed. The work shows that CUMS is a reliable model for studying depression, and the noninvasive urinary metabolomic method is a valuable tool to investigate the biochemical pertubations in depression as an early diagnostic means. Copyright © 2012 John Wiley & Sons, Ltd.     

Metabonomics Study of Heart Homogenates from Myocardial Infarction Rats Using Liquid Chromatography/Time of Flight Mass Spectrometry

In this study, a metabonomics analysis of heart homogenates from myocardial ischemic rats was performed by LC–TOF–MS. Hydrophilic interaction chromatography (HILIC) was used to separate the endogenous metabolites in heart homogenates. Partial least squares to latent structure-discriminant analysis (PLS-DA) was used for data analysis. Good separations were observed between the normal and model groups and 15 potential biomarkers were identified. The major disturbed metabolic pathways were purine metabolism, pyrimidine metabolism, urea cycle, and energy metabolism. The results demonstrated that a metabonomics approach based on HILIC-MS was useful for studying metabolic mechanism on target tissue of the myocardial infarction rat.

     

Metabonomics study of the effects of traditional Chinese medicine formula Ermiaowan on hyperuricemic rats

To explore the global mechanism of Ermiaowan on hyperuricemia regulation, the holistic function of Ermiaowan for hyperuricemia in rats was firstly assessed by the urinary metabonomics method which was based on ultra‐high performance liquid chromatography with electrospray ionization quadrupole time‐of‐flight mass spectrometry. The urinary targeted metabonomics approach combined with the serum biochemical analysis and histological assay was conducted to verify the research result. As a result, the significant differences in metabolic profiles were observed from Ermiaowan‐treated group, model group, and healthy control group by using multivariate statistical approaches. Twenty therapeutic related metabolites were identified in response to the therapeutic effects of Ermiaowan, which were mainly associated with purine metabolism, pyrimidine metabolism, tryptophan metabolism, tricarboxylic acid cycle, and tyrosine metabolism. In addition, the urinary targeted metabonomics study showed that Ermiaowan can better restore the disturbed pathways than Phellodendri cortex and Atractylodis rhizome. The biochemical assay and histopathological assay confirmed that Ermiaowan could significantly reduce uric acid and fibrosis areas of kidney. These results provided new insights into the mechanism of Ermiaowan on hyperuricemia.     

Therapeutic Effects of Selaginella tamariscina on the Model of Acute Gout with Hyperuricemia in Rats Based on Metabolomics Analysis

Gout is a disease of purine metabolic disorders which results from long‐term hyperuricemia and the sodium urate deposition in and around the joints. Selaginella tamariscina (ST ) is an important traditional Chinese herbal medicine and is used for the treatment of gout and hyperuricemia. In this study, the rat model of acute gout with hyperuricemia was established by intraperitoneal injection of xanthine and oxonic acid potassium salt and articular injection monosodium urate (MSU ). The effect of ST in the treatment of gout was investigated by measuring joint swelling, the expression of IL ‐1β in serum and histological changes of joint by haematoxylin eosin (H&E) staining. Subsequently, urine metabolomics analysis for biomarkers discovery in acute gout with hyperuricemia rats was performed by the ultra‐performance liquid chromatography‐electrospray ionization quadruple time‐of‐flight mass spectrometry (UPLC‐ESI‐QTOF /MS ) combined with chemometric approach. Principal component analysis (PCA ) and orthogonal partial least squares‐discriminant analysis (OPLS‐DA ) were used to detect potential biomarkers. A total of 18 potential biomarkers were identified mainly including tryptophan metabolism; tyrosine metabolism; lysine methylation; pyrimidine metabolism; purine metabolism; TCA cycle and fatty acid metabolisms. This study indicates that ST could efficiently ameliorate the disease of acute gout with hyperuricemia in rats. The related metabolic biomarkers could provide useful information and the metabolic mechanism could be used for further study about the model of acute gout with hyperuricemia in rats.     

中药质谱分析方法及应用研究

分别从中药成分分析、活性筛选和代谢组学三方面对质谱技术在中药研究中的应用进展进行了全面综述.在中药成分分析方面,重点介绍了寡糖异构体的分析方法,以及质谱指纹图谱技术在中药成分分析及质量控制中的应用;在活性筛选方面,分别介绍了超滤-质谱、细胞膜色谱-质谱、微透析-质谱、亲和色谱-质谱、强度衰减质谱、修饰琼脂糖珠-质谱和直接分析质谱等技术及其应用;在代谢组学研究方面,对中药治疗肝损伤、肾虚、心肌梗死和糖尿病等疾病方面的研究进展进行了阐述.上述内容充分反映了质谱技术在中药创新性研究中的重要性.